Evan Loh, CEO at Paratek Pharmaceuticals, Inc. (PRTK), sold 73,308 shares at $9.70 ($711K) on 2021-06-04, disclosed to the SEC on 2021-06-08.
Open-market sale of $711k PRTK by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.70 | 36,654 | $356K | 50.0% |
| 2 | $9.70 | 36,654 | $356K | 50.0% |
| Total | $9.70 avg | 73,308 | $711K | 100% |
| Filing → |
| PRTK | SELL | 2022-12-14 | $393K | — | Filing → |
| PRTK | SELL | 2022-11-01 | $31K | — | Filing → |
| PRTK | SELL | 2022-08-10 | $237K | — | Filing → |